GlassScriptPhysician profile
Matthew S Burge
NPI 1902169808
$6,860.94
in general payments reported to CMS, 2019-2025
17 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,706 · 2020: $464 · 2021: $1,327 · 2022: $15.63 · 2023: $71.97 · 2024: $130 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,592.47 | 2019-2023 | Da Vinci Surgical System |
| Stryker Corporation | $1,327.32 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $463.90 | 2020 | |
| Davol INC. | $91.00 | 2019 | |
| Ethicon US, LLC | $88.36 | 2022-2025 | Vistaseal, Ethicon, Stratafix |
| Highridge Medical LLC | $82.25 | 2024 | Vital |
| Innovation Technologies INC | $30.61 | 2024 | Irrisept |
| Urgo Medical North America, LLC | $30.50 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Smith+Nephew, INC. | $25.15 | 2019-2023 | Oasis |
| Vertex Pharmaceuticals Incorporated | $23.10 | 2025 | |
| Teleflex LLC | $20.19 | 2025 | Quikclot |
| Acera Surgical, INC. | $17.00 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $16.16 | 2025 | Spyglass Discover |
| Integra Lifesciences Corporation | $14.51 | 2023 | Integra, Integra Dermal Regeneration Template |
| Ossur Americas, INC. | $14.48 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Biosciences INC | $12.40 | 2019 | |
| Csl Behring | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Burge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.